...defective viral particles that mimic and outcompete infectious viruses University of Warwick Infectious Abingworth Management Critical Pressure Ltd....

...S. aureus toxin antigens for pneumonia, although none has a wide-ranging anti-toxin strategy. Another newco, Critical Pressure Ltd....
...and Institutions Mentioned Arytha Biosciences LLC, San Diego, Calif. Cellics Therapeutics Inc., San Diego, Calif. Critical Pressure Ltd....

...based on endogenous vasoconstrictors like norepinephrine, are used off-label for septic shock. But according to Critical Pressure...
...can lead to excessive vasoconstriction that cuts off blood flow to the extremities. Leiper said Critical Pressure’s...
...London. IP covering the molecule was transferred to Leiper in 2014, who re-assigned it to Critical Pressure...

...compound was discovered at University College London in a project funded by the Wellcome Trust. Critical Pressure...
...the newco. Grainger told BioCentury that in a pre-IND meeting with FDA, the agency said Critical Pressure...
...III trial to treat septic shock (see BioCentury, Oct. 31, 2011 ). Critical Pressure Ltd., Cambridge, U.K. Alicia Parker Critical Pressure Ltd....

...compound was discovered at University College London in a project funded by the Wellcome Trust. Critical Pressure...
...the newco. Grainger told BioCentury that in a pre-IND meeting with FDA, the agency said Critical Pressure...
...III trial to treat septic shock (see BioCentury Extra, Oct. 25, 2011) . Virginia Li CPL001 Critical Pressure Ltd. Dimethylarginine dimethylaminohydrolase1 (DDAH1) Critical Pressure Ltd....